From: Re-implantation after insufficient primary 125-i permanent prostate brachytherapy
Number of patients RI / control | Baseline 5 / 137 | 6 weeks 5 / 136 | 6 months 5 / 142 | 1 year 4 / 130 | 2 years 3 / 115 | 3 years 2 / 90 |
---|---|---|---|---|---|---|
Residual urine (ml) Control: | 0 [0-0] 23.3 [0-300] | 48 [20-80] 55.8 [0-900] | 58 [20-90] 39.8 [0-400] | 32.5 [0-100] 24 [0-200] | 18 [6-30] 16.1 [0-122] | 0 [0-0] 17.4 [0-200] |
Residual urine (ml/s) Control: | 20.8 [16.1-32] 18.5 [5.5-40] | 15.2 [10.3-18.8] 11.1 [7-26] | 11.6 [9.4-14.1] 12.6 [3.3-35] | 16.3 [13.5-19] 14.6 [4.1-35.7] | 20.4 [18.4-24.1] 16.1 [3.8-40] | 19.8 [17.4-22.1] 15.1 [2.2-34.8] |
IPSS Control: | 5.7 [3-11] 5.8 [0-22] | 11.7 [7-19] 15.3 [1-34] | 14.3 [11-19] 12.7 [0-34] | 12.3 [7-15] 10.3 [1-26] | 9.0 [6-12] 9.5 [0-26] | 6.5 [4-9] 7.5 [1-28] |
IPSS-QoL Control: | 0.7 [0-1] 0.96 [0-5] | 2.7 [1-4] 2.6 [0-6] | 2.5 [1-4] 2.2 [0-6] | 2.3 [1-4] 1.7 [0-6] | 2.0 [1-3] 1.5 [0-5] | 2.0 [1-3] 1.2 [0-5] |